Himalayan Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 1.24 Cr
as on 23-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 Cr
as on 23-12-2024
- Revenue 5727.82%
(FY 2023)
- Profit 194.67%
(FY 2023)
- Ebitda 605.41%
(FY 2023)
- Net Worth 2.94%
(FY 2023)
- Total Assets 23.00%
(FY 2023)
About Himalayan Nutraceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.24 Cr.
The company currently has active open charges totaling ₹7.00 Cr.
Akarsh Mittal and Ayush Goel serve as directors at the Company.
- CIN/LLPIN
U24110UR2021PTC012358
- Company No.
012358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Udham Singh Nagar, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Himalayan Nutraceuticals Private Limited offer?
Himalayan Nutraceuticals Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Fruit Extracts, Herbal Extracts, Plant Extracts, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Root and Vegetable Extracts, Fresh, Dried & Preserved Fruits, Fruit Powder, Cooking Spices and Masala.
Who are the key members and board of directors at Himalayan Nutraceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akarsh Mittal  | Director | 28-Apr-2021 | Current |
| Ayush Goel | Additional Director | 12-May-2021 | Current |
Financial Performance of Himalayan Nutraceuticals.
Himalayan Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 5727.82% increase. The company also saw a substantial improvement in profitability, with a 194.67% increase in profit. The company's net worth moved up by a moderate rise of 2.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Himalayan Nutraceuticals?
In 2023, Himalayan Nutraceuticals had a public holding of 72.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 May 2023 | ₹3.00 Cr | Open |
Others Creation Date: 18 Sep 2021 | ₹4.00 Cr | Open |
How Many Employees Work at Himalayan Nutraceuticals?
Himalayan Nutraceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Himalayan Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Himalayan Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
